Simcere Pharmaceutical Group Ltd Ordinary Shares SMHGF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.76
- Day Range
- $0.69–0.69
- 52-Week Range
- $0.76–0.76
- Bid/Ask
- $0.00 / $400.78
- Market Cap
- $1.81 Bil
- Volume/Avg
- 100 / 1,000
Key Statistics
- Price/Earnings (Normalized)
- 9.61
- Price/Sales
- 1.93
- Dividend Yield (Trailing)
- 3.24%
- Dividend Yield (Forward)
- 3.21%
- Total Yield
- 5.55%
Company Profile
Simcere Pharmaceutical Group Ltd is engaged in the R&D, production, and commercialization of pharmaceuticals focused on generic pharmaceuticals. It has a diversified product portfolio focused on therapeutic areas, including, oncology (including cell therapy), nervous system diseases, autoimmune diseases, and antiinfection. The company's products include Endostar, Enweida, Iremod, Sanbexin and Others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 7,027
- Website
- https://www.simcere.com
Comparables
Valuation
|
Metric
|
SMHGF
|
600380
|
002826
|
|---|---|---|---|
Price/Earnings (Normalized) | 9.61 | 16.36 | 35.82 |
Price/Book Value | 1.78 | 1.59 | 2.27 |
Price/Sales | 1.93 | 1.40 | 2.53 |
Price/Cash Flow | 12.03 | 4.94 | 8.80 |
Price/Earnings
SMHGF
600380
002826
Financial Strength
|
Metric
|
SMHGF
|
600380
|
002826
|
|---|---|---|---|
Quick Ratio | 2.07 | — | 2.58 |
Current Ratio | 2.35 | — | 2.85 |
Interest Coverage | 92.05 | — | 51.03 |
Quick Ratio
SMHGF
600380
002826
Profitability
|
Metric
|
SMHGF
|
600380
|
002826
|
|---|---|---|---|
Return on Assets (Normalized) | 6.97% | — | 4.73% |
Return on Equity (Normalized) | 10.22% | — | 6.14% |
Return on Invested Capital (Normalized) | 8.48% | — | 5.70% |
Return on Assets
SMHGF
600380
002826
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Rmrswbyql | Gkrdt | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Wqwyvvpcm | Zfflch | $70.0 Bil | |
HLN
| Haleon PLC ADR | Lxnlqds | Jrfjw | $37.6 Bil | |
VTRS
| Viatris Inc | Gflzgrp | Crgg | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Zcthwcks | Xhnbs | $12.4 Bil | |
CTLT
| Catalent Inc | Htxqrddq | Bpxnvfq | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Pljmzqny | Sgwd | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Pmzxtgv | Yyrv | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Bjmytmdmc | Gzfnbd | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Fzqlcnvf | Tllr | $3.2 Bil |